HBV相关性肝癌患者合并不同程度肝硬化对预后的影响

摘要/Abstract

摘要： 目的研究乙肝相关性肝癌合并不同程度肝硬化对预后的影响。方法纳入2016年1月至2020年10月收治的108例乙肝相关性肝癌患者作为研究对象,随访记录患者的生存率,比较不同肝硬化程度患者临床病理特征指标水平,分析肝硬化程度与预后的关系。结果 108例患者随访2～56个月,死亡26例,生存率75.93%。不同程度肝硬化患者预后差异有统计学意义(P<0.05)。不同肝硬化程度患者肿瘤分化程度、血管侵犯及肿瘤分期水平比较,差异均有统计学意义(P<0.05)。Cox多因素风险回归模型分析显示,分化情况(95%CI=1.859~4.887,HR=3.014,P<0.001)、血管侵犯(95%CI=1.075~7.403,HR=2.821,P=0.035)、肿瘤分期(95%CI=1.602~3.867,HR=2.489,P<0.001)、治疗方案(95%CI=1.462~2.971,HR=2.084,P<0.001)及肝硬化程度(95%CI=1.118~1.580,HR=1.329,P=0.001)是乙肝相关性肝癌预后的独立影响因素(P<0.05)。根据Cox分析结果建立预测模型:Y₂=1.103X₁+1.037X₂+0.912X₃+0.734X₄+0.284X₅(X₁=分化程度,X₂=血管侵犯,X₃=肿瘤分期,X₄=治疗情况,X₅=肝硬化程度)。该模型判断预后的AUC为0.840(SE=0.042,95%CI=0.758~0.922,P<0.001)。结论乙肝相关性肝癌患者合并肝硬化程度与预后密切相关,基于肝硬化程度建立的预测模型对判断预后具有较高准确性。

关键词: 乙型肝炎病毒, 肝癌, 肝硬化, 预后

Abstract: Objective To investigate the influence of different degrees of cirrhosis on the prognosis of the patients with hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC).Methods One hundred and eight patients with HBV-HCC from January 2016 to October 2020 were enrolled as the research subjects. The survival rate was calculated. The levels of clinicopathological characteristics of patients with different degrees of cirrhosis were compared. The relationship between the degree of cirrhosis and prognosis was analyzed.Results During 2- to 56-month follow-up, 26 of the 108 patients died. The survival rate was 75.93%. The prognosis of patients with different degrees of liver cirrhosis was significantly different (P<0.05). There were significant differences in tumor differentiation, vascular invasion and tumor staging among patients with different degrees of cirrhosis (P<0.05). The Cox multivariate regression model showed that the differentiation degree [95% confidence interval (CI) = 1.859~4.887, hazard ratio (HR) = 3.014, P<0.001], vascular invasion (95%CI=1.075~7.403, HR=2.821, P=0.035), tumor stage (95%CI=1.602~3.867, HR=2.489, P<0.001), treatment plan (95%CI=1.462~2.971, HR=2.084, P<0.001) and the degree of cirrhosis (95%CI=1.118~1.580, HR=1.329, P=0.001) were independent factors for the prognosis of HBV-HCC. According to Cox analysis, the prediction model was as follows: Y₂=1.103×X₁+1.037×X₂+0.912×X₃+0.734×X₄+0.284×X₅ (X₁=degree of differentiation, X₂ = vascular invasion, X₃ = tumor stage, X₄ = treatment, X₅ = degree of cirrhosis). Area under the curve (AUC) of the model to predict the prognosis was 0.840 (sensitivity = 0.042, 95%CI = 0.758-0.922, P<0.001).Conclusion The degree of liver cirrhosis in patients with HBV-HCC is closely related to the prognosis, and the prediction model based on the degree of liver cirrhosis has a high accuracy in predicting the prognosis.

Key words: Hepatitis B virus, Liver cancer, Liver cirrhosis, Prognosis

沈宇, 万伟, 立全晰, 吴星星. HBV相关性肝癌患者合并不同程度肝硬化对预后的影响[J]. 肝脏, 2021, 26(5): 530-533.

SHEN Yu, WAN Wei, LI Quan-xi, WU Xing-xing. The influence of different degrees of cirrhosis on the prognosis of patients with hepatitis B virus-associated hepatocellular carcinoma[J]. Chinese Hepatolgy, 2021, 26(5): 530-533.

参考文献

[1] 肖静,黄建萍,张敏,等.南通地区1999至2011年肝癌死亡率的变动趋势和今后5年发展趋势的预测. 中华肝脏病杂志, 2015,23:663-668.
[2] 陈文军, 王俊娟, 祁建妮,等. 慢性乙型肝炎病毒感染患者发生肝细胞肝癌风险预测的研究进展. 国际肿瘤学杂志, 2019, 46:558-561.
[3] 焦扬.乙肝病毒阳性与阴性原发性肝癌患者的临床特征.中华肝胆外科杂志,2017,23:217-221.
[4] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015更新版).肝脏,2015,20:915-932.
[5] 中国抗癌协会肝癌专业委员会,中华医学会肝病学分会肝癌学组,中国抗癌协会病理专业委员会, 等.原发性肝癌规范化病理诊断指南(2015年版).中华肝胆外科杂志,2015,21:145-151.
[6] Braillon A . Laennec's cirrhosis. Lancet, 2019, 393:131-132.
[7] Zhang EL, Liang BY, Chen XP, et al. Severity of liver cirrhosis: a key role in the selection of surgical modality for Child-Pugh A hepatocellular carcinoma.World J Surg Oncol, 2015, 13:1-7.
[8] 黎莉, 杨卫文, 魏涛,等. 乙型肝炎肝硬化并发原发性肝癌的危险因素Logistic分析. 中国老年学杂志, 2016, 36:1653-1654.
[9] Nilsson E, Anderson H, Sargenti K, et al. Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based study. Scand J Gastroenterol, 2019, 54:1027-1032.
[10] 朱海涛,孙诚谊.肝硬化对乙肝相关性肝癌根治术预后的影响.中国现代医学杂志,2018,28:57-60.
[11] 古川,宋美怡,孙文静, 等.2016年肝硬化领域基础与临床研究进展.中华肝脏病杂志,2017,25:5-8.
[12] Kozaka K, Kobayashi S, Yoneda N, et al. Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features. Eur Radiol, 2019, 29:6489-6498.
[13] 韩志钧, 马金彤, 韩柠泽. 门静脉充血指数和血流量与肝储备功能的相关性分析. 中国超声医学杂志, 2019,35:511-513.
[14] Groarke JD. Cardiovascular vulnerability of childhood cancer survivors: time to progress from risk observation to risk modification. Eur Heart J,2018,39:1563-1566.
[15] 张振, 王孟龙, 张海涛,等. 肝硬化门静脉高压患者脾切除断流术后早期门静脉血栓形成的因素及预防性活血、抗凝、祛聚治疗的效果. 肝脏, 2019, 24:24-27,89.
[16] 任莎莎, 简文, 刘自明. 系统免疫炎症指数和骨骼肌质量指数与肝硬化合并肝癌患者术后预后的关系. 现代肿瘤医学, 2020,292:85-89.